AzTrials
AzTrials

Older AdultsNCT03493373

Effect of Nervous System Mobilization on Older Adults' Postural Control

A study testing Exercise and Neural mobilization in people with Older Adults, run by Aveiro University at 2 sites in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to compare the effectiveness of nervous system mobilization and exercise with exercise only on institutionalized older adults' postural control. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Older Adults
What is being tested?
Exercise and Neural mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
2 sitesPortugal
Study dates
15 Apr 2018to 21 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • be 65 years of age or older;
  • to have independent gait with or without technical aid;
  • have indication of the institution's doctor for participation in the study

Who cannot join

  • inability to understand study aims.

Trial locations and contacts

2 sites in 1 country.

Portugal2 sites
  • Lar Santa Catarina do Reboleiro

    Guarda, 3810-193

  • Lar da Santa Cruz da Beselga

    Guarda

Other trials in Portugal

About this study

This study aims to compare the effectiveness of nervous system mobilization and exercise with exercise only on institutionalized older adults' postural control.

Read the detailed description

It is anticipated that 26 institutionalized older adults will be randomly allocated to receive either exercise and neural mobilization (n=13) or exercise only (n=13).

Data on pain intensity (a vertical numeric rating scale) and location (body chart), depression (Geriatric Depression Scale), balance, hand grip strength, timed up and go and gait velocity will be collected at baseline, end of treatment and at 3 months follow up.

Statistical analysis will be performed using a mixed-methods ANOVA.

Conditions
Older Adults
Being tested
Exercise, Neural mobilization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    The exercise program will consist of: 1) warm up - consisting of stretches of large muscle groups of the upper limbs, lower limbs and trunk and by general mobility exercises; 2) strength training of moderate intensity; 3) balance training; 4) Cooling - will consist of performing overall stretching combined with deep breathing.

  • Neural mobilizationOther

    Neural gliding mobilization will target mainly the lower limb nerves and will be performed in series of 10 repetitions with 1 minute interval between series.

Study groups in NCT03493373
Study groupRoleWhat they receive
Exercise and nervous system mobilizationExperimentalThis group will receive neural mobilization and therapeutic exercise: two sessions of 60 minutes during 8 weeks.
Receives: Other: Exercise; Other: Neural mobilization
ExerciseExperimentalThis group will receive therapeutic exercise: two sessions of 60 minutes during 8 weeks.
Receives: Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait velocity

    Participants are asked to walk at normal gait velocity over 4 meters and gait velocity is calculated

    Measured: Baseline

  2. Gait velocity

    Participants are asked to walk at normal gait velocity over 4 meters and gait velocity is calculated

    Measured: 9 weeks

  3. Gait velocity

    Participants are asked to walk at normal gait velocity over 4 meters and gait velocity is calculated

    Measured: 3 months

Secondary outcomes (15)
  1. Pain intensity

    Pain intensity measured using a vertical numeric rating scale (Range: 0 to 10 and higher values are indicative of higher pain intensity)

    Measured: Baseline

  2. Pain intensity

    Pain intensity measured using a vertical numeric rating scale (Range: 0 to 10 and higher values are indicative of higher pain intensity)

    Measured: 9 weeks

  3. Pain intensity

    Pain intensity measured using a vertical numeric rating scale (Range: 0 to 10 and higher values are indicative of higher pain intensity)

    Measured: 3 months

  4. Pain location

    Measured using a body chart (a graphic representation of the body) where participants identify painful body sites

    Measured: Baseline

  5. Pain location

    Measured using a body chart (a graphic representation of the body) where participants identify painful body sites

    Measured: 9 weeks

  6. Pain location

    Measured using a body chart (a graphic representation of the body) where participants identify painful body sites

    Measured: 3 months

  7. Depressive symptoms

    Measured using the 15-itens Geriatric Depression Scale (range: 0-15; participants who score 5 or more have depression)

    Measured: Baseline

  8. Depressive symptoms

    Measured using the 15-itens Geriatric Depression Scale (range: 0-15; participants who score 5 or more have depression)

    Measured: 9 weeks

  9. Depressive symptoms

    Measured using the 15-itens Geriatric Depression Scale (range: 0-15; participants who score 5 or more have depression)

    Measured: 3 months

  10. Balance

    Participants are asked to maintain a tandem/semi-tandem position for up to 30 seconds.

    Measured: Baseline

  11. Balance

    Participants are asked to maintain a tandem/semi-tandem position for up to 30 seconds.

    Measured: 9 weeks

  12. Balance

    Participants are asked to maintain a tandem/semi-tandem position for up to 30 seconds.

    Measured: 3 months

  13. Timed up and go test

    Get up from a chair, walk 3 meters, go back to the chair and sit back. The amount of time that each participant takes to perform the task is taken.

    Measured: Baseline

  14. Timed up and go test

    Get up from a chair, walk 3 meters, go back to the chair and sit back.The amount of time that each participant takes to perform the task is taken.

    Measured: 9 weeks

  15. Timed up and go test

    Get up from a chair, walk 3 meters, go back to the chair and sit back. The amount of time that each participant takes to perform the task is taken.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2018
  2. Study start15 Apr 2018
  3. Primary completion15 Dec 2018
  4. Study completion21 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03493373
Sponsor's protocol ID
5/2018
Status last verified
Mar 2019
First submitted
4 Apr 2018
Last updated
26 Mar 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Neural mobilization in people with Older Adults, run by Aveiro University at 2 sites in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait velocity (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in